Lu Wen

Mechanism underlying the immune checkpoint inhibitor-induced hyper-progressive state of cancer

F. Tong, Rui-guang Zhang, Xiaorong Dong, 2022, Cancer drug resistance.

Detecting Cancer Stem Cell Markers Via Mid-to High- Throughput Profiling Real-Time Pcr

M. Wicha, J. Moon, Lu Wen, 2018 .

The Research Progress of PD-1/PD-L1 Inhibitors Enhancing Radiotherapy Efficacy

F. Tong, Rui-guang Zhang, Yu Huang, 2021, Frontiers in Oncology.

Single-cell RNA-Seq reveals the potential risk of anti-mesothelin CAR T Cell therapy toxicity to different organs in humans

F. Tong, Rui-guang Zhang, Xiaorong Dong, 2022, Frontiers in Immunology.

T Cell-Mediated Tumor Killing-Related Classification of the Immune Microenvironment and Prognosis Prediction of Lung Adenocarcinoma

F. Tong, Rui-guang Zhang, Yu Huang, 2022, Journal of clinical medicine.

HER2-targeted antibody-drug conjugate induces host immunity against cancer stem cells.

A. Chang, M. Wicha, S. Coats, 2021, Cell chemical biology.

Relationship between Autophagy and Drug Resistance in Tumors.

Chuanying Zhu, Lu Wen, Xianfeng Li, 2022, Mini-Reviews in Medical Chemistry.